Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
294
Frequently Asked Questions
What is Market Cap of Akcea Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Akcea Therapeutics Inc market cap is $1.85B.
What is the 52-week high for Akcea Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Akcea Therapeutics Inc 52 week high is $21.71 as of October 06, 2025.
What is the 52-week low for Akcea Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Akcea Therapeutics Inc 52 week low is $8.00 as of October 06, 2025.
What is Akcea Therapeutics Inc stock price today?
Akcea Therapeutics Inc stock price today is $18.17.
What was Akcea Therapeutics Inc stock price yesterday?
Akcea Therapeutics Inc stock price yesterday was $18.14.
What is the PE ratio of Akcea Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Akcea Therapeutics Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Akcea Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Akcea Therapeutics Inc P/B ratio is 3.8503.
What is Akcea Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Akcea Therapeutics Inc's EBITDA is -14.92.
What is the 50-day moving average of Akcea Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Akcea Therapeutics Inc 50-day moving average is $15.46.
How many employess does Akcea Therapeutics Inc has?